BioCryst Pharmaceuticals Down 23.3% Since SmarTrend Downtrend Call (BCRX)

SmarTrend identified a Downtrend for BioCryst Pharmaceuticals (NASDAQ:BCRX) on August 6th, 2015 at $14.59. In approximately 3 weeks, BioCryst Pharmaceuticals has returned 23.34% as of today's recent price of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.